BeiGene, Ltd. Operating Expenses 2011-2026 | BGNE

Annual Operating Expenses BeiGene, Ltd.

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	390 M	196 M	62.9 M	20.1 M	7.31 M	6.93 M	3.14 M	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
390 M	3.14 M	98 M

Quarterly Operating Expenses BeiGene, Ltd.

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	21 M	-	-	-	11.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
21 M	11.2 M	16.1 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Amgen AMGN	9.33 B	$ 350.62	0.81 %	$ 189 B	USA
Heron Therapeutics HRTX	281 M	$ 0.8	2.35 %	$ 133 M	USA
Altimmune ALT	94.5 M	$ 3.46	3.44 %	$ 305 M	USA
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	78.3 M	-	2.54 %	$ 160 B	France
Ascendis Pharma A/S ASND	338 M	$ 219.42	-1.11 %	$ 5 B	Danmark
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
ARCA biopharma ABIO	88.1 M	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	23 M	-	5.93 %	$ 314 M	Canada
Incyte Corporation INCY	1.62 B	$ 90.74	-0.04 %	$ 17.7 B	USA
AgeX Therapeutics AGE	10.1 M	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
Albireo Pharma ALBO	163 M	-	-0.23 %	$ 916 M	USA
Inovio Pharmaceuticals INO	145 M	$ 1.62	2.22 %	$ 35.9 M	USA
Aileron Therapeutics ALRN	65.1 M	-	10.36 %	$ 9.8 M	USA
Acasti Pharma ACST	24.4 M	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Avenue Therapeutics ATXI	5.21 K	-	-52.27 %	$ 4.45 M	USA
Adverum Biotechnologies ADVM	140 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	24.6 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	22 M	-	-9.65 %	$ 45.9 M	USA
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
Cullinan Management CGEM	242 M	$ 12.92	1.41 %	$ 778 M	USA
Inventiva S.A. IVA	36.2 M	$ 6.13	6.06 %	$ 138 M	France
Atreca BCEL	98.7 M	-	-11.76 %	$ 5.79 M	USA
BioDelivery Sciences International BDSI	106 M	-	-4.8 %	$ 255 M	USA
KalVista Pharmaceuticals KALV	188 M	$ 16.76	-1.41 %	$ 832 M	Britain
Calithera Biosciences CALA	125 M	-	-10.95 %	$ 876 K	USA
Cara Therapeutics CARA	142 M	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	120 M	-	-	$ 3.74 B	USA
Bellerophon Therapeutics BLPH	22.4 M	-	-74.18 %	$ 955 K	USA
Kamada Ltd. KMDA	69 K	$ 8.23	-0.24 %	$ 260 M	Israel
Checkpoint Therapeutics CKPT	56.2 M	-	-	$ 169 M	USA
Karyopharm Therapeutics KPTI	265 M	$ 7.06	-7.47 %	$ 860 K	USA
Clovis Oncology CLVS	425 M	-	-7.23 %	$ 13 M	USA
Keros Therapeutics KROS	176 M	$ 11.27	2.83 %	$ 419 M	USA
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
Denali Therapeutics DNLI	502 M	$ 21.23	5.26 %	$ 3.49 B	USA
Longeveron LGVN	24.1 M	$ 0.95	-3.52 %	$ 16.7 B	USA
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Arbutus Biopharma Corporation ABUS	96.2 M	$ 4.3	1.3 %	$ 714 M	Canada
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
AIkido Pharma AIKI	29.7 M	-	1.93 %	$ 17.4 M	USA